Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

Related Party Transactions (Details Narrative)														9 Months Ended		12 Months Ended
Related Party Transactions (Details Narrative)	Jul. 13, 2020 AUD ($)	May 14, 2019 USD ($) $ / shares shares	May 14, 2019 AUD ($) shares	Mar. 16, 2018 USD ($)	Mar. 16, 2018 AUD ($)	Feb. 01, 2018 USD ($)	Feb. 01, 2018 AUD ($)	May 05, 2016 USD ($)	May 05, 2016 USD ($)	May 05, 2016 AUD ($)	Feb. 25, 2016 USD ($)	Feb. 25, 2016 AUD ($)	Feb. 25, 2015 AUD ($)	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 31, 2021 AUD ($) shares	Jun. 30, 2020 USD ($)	Jun. 30, 2020 AUD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2019 AUD ($)	Mar. 31, 2021 AUD ($)	May 05, 2016 AUD ($)
Loans from related party														$ 56,366		$ 50,993
Due to related parties														$ 33,867		30,639
Exercise price \| $ / shares
Granted exercise price \| $ / shares
Accrued salaries														$ 92,547
Chief Executive Officer [Member]
Payments form related party														127,165		136,606		$ 64,377
Bonus payable amount																		137,120
Remaining bonus amount																		$ 178,256
Bonus payable														179,372		280,726
Nathanielsz Employment Agreement [Member]
Expired date													Feb. 25, 2019
Annual salary														$ 205,680
Percentage of pension of monthly salary														9.50%	9.50%
Percentage of bonus of annual base salary														200.00%	200.00%
Nathanielsz Employment Agreement [Member] \| Minimum [Member]
Annual salary				$ 205,680
Nathanielsz Employment Agreement [Member] \| Maximum [Member]
Annual salary				$ 274,240
Employment Agreement [Member]
Restricted stock unit issuable \| shares														39	39
Services Agreement [Member]
Restricted stock unit issuable \| shares														20	20
AUD Currency [Member]
Accrued salaries																				$ 121,500
AUD Currency [Member] \| Chief Executive Officer [Member]
Payments form related party															$ 171,890		$ 202,620		$ 90,000
Bonus payable amount																			200,000
Remaining bonus amount																			$ 260,000
Bonus payable														$ 235,490		407,380
AUD Currency [Member] \| Nathanielsz Employment Agreement [Member]
Annual salary													$ 25,000		300,000
AUD Currency [Member] \| Nathanielsz Employment Agreement [Member] \| Minimum [Member]
Annual salary					$ 300,000
AUD Currency [Member] \| Nathanielsz Employment Agreement [Member] \| Maximum [Member]
Annual salary					$ 400,000
Initial Nathanielsz RSUs [Member] \| Employment Agreement [Member]
Restricted stock shares of common stock \| shares		39	39
Additional Nathanielsz RSUs [Member] \| Employment Agreement [Member]
Restricted stock shares of common stock \| shares		39	39
Rsus vest, shares \| shares		7.80	7.80
Gross proceeds from equity financing		$ 4,000,000
Initial Kenyon RSUs [Member] \| Services Agreement [Member]
Restricted stock shares of common stock \| shares		20	20
Additional Kenyon RSUs [Member] \| Services Agreement [Member]
Restricted stock shares of common stock \| shares		20	20
Rsus vest, shares \| shares		5	5
Gross proceeds from equity financing		$ 4,000,000
North Horizon Pty Ltd [Member]
Lease term								5 years	5 years												5 years
Lease expiration date								May 31, 2021
Annual rental payments									$ 28,325
Goods and service tax									2,575
Future minimum payments due														7,833
Rent payable														58,462
North Horizon Pty Ltd [Member] \| AUD Currency [Member]
Annual rental payments										$ 39,600
Goods and service tax										$ 3,600
North Horizon Pty Ltd [Member] \| AUD Currency [Member]
Future minimum payments due																				$ 10,283
Rent payable															76,752
Current and Former Director [Member]
Loans from related party														56,366		50,993
Former Director [Member]
Due to related parties														33,867		$ 30,639
Nathanielsz [Member] \| North Horizon Pty Ltd [Member]
Future minimum payments due								$ 141,629	$ 141,629
Nathanielsz [Member] \| North Horizon Pty Ltd [Member] \| AUD Currency [Member]
Future minimum payments due																					$ 198,000
Mr. Nathanielsz [Member]
Annual salary						$ 80,904
Payments form related party														$ 26,356
Mr. Nathanielsz [Member] \| AUD Currency [Member]
Annual salary							$ 120,000
Mr. Nathanielsz [Member] \| AUD Currency [Member]
Payments form related party															$ 34,601
James Nathanielsz [Member]
Payments form related party											$ 3,205
James Nathanielsz [Member] \| AUD Currency [Member]
Payments form related party												$ 4,481
Mr. Nathanielsz [Member] \| Board of Directors [Member]
Officers' compensation		$ 315,376
Mr. Nathanielsz [Member] \| Employment Agreement [Member]
Agreement term		3 years	3 years
Agreement renewal term		1 year	1 year
Option purchase shares \| shares		39	39
Exercise price \| $ / shares		$ 4,675
Market price		110.00%	110.00%
Granted exercise price \| $ / shares		$ 4,250
Option term		10 years	10 years
Options vested, description		The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz's continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz's continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the "CTA") for PRP, the Company's lead product candidate ("PRP"), for a First-In-Human study for PRP (the "Study") in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit, (iii) the date of Mr. Nathanielsz's death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz's employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall vest immediately prior to such event.	The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz's continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz's continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the "CTA") for PRP, the Company's lead product candidate ("PRP"), for a First-In-Human study for PRP (the "Study") in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit, (iii) the date of Mr. Nathanielsz's death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz's employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall vest immediately prior to such event.
Mr. Nathanielsz [Member] \| AUD Currency [Member] \| Board of Directors [Member]
Officers' compensation	$ 240,000		$ 460,000
Bonus granted percentage	60.00%
Mr. Nathanielsz [Member] \| AUD Currency [Member] \| Employment Agreement [Member]
Annual salary			400,000
Dr Kenyon [Member] \| AUD Currency [Member] \| Services Agreement [Member]
Annual salary			$ 54,000
Dr Kenyon [Member] \| Services Agreement [Member]
Agreement term		3 years	3 years
Agreement renewal term		1 year	1 year
Option purchase shares \| shares		20	20
Exercise price \| $ / shares		$ 4,250
Market price		100.00%	100.00%
Option term		10 years	10 years
Options vested, description		The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon's continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon's continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement), (ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon's death or Disability (as defined in the Services Agreement), and (iv) Dr. Kenyon's employment being terminated either by the Company without Cause or by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event.	The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon's continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon's continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement), (ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon's death or Disability (as defined in the Services Agreement), and (iv) Dr. Kenyon's employment being terminated either by the Company without Cause or by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event.